41 completed, 20 unknown, 11 recruiting, 5 not yet recruiting. 19 Not applicable, 17 Phase 2, 11 Phase 3, 2 Phase 1, 2 Phase 4.
Follow Tuberculosis, Extrapulmonary: new trials by email Literature Review of Tuberculosis, Extrapulmonary trials Research Report on Tuberculosis, Extrapulmonary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MBLA to Differentiate IRIS From Treatment Failure in Extrapulmonary Tuberculosis MBLA from routine lymph node aspirate - Extrapulmonary Tuberculosis | Not yet recruiting | Research Center Borstel | 100 | 2026-09-01 | 2026-08-31 | |
| BPaLMZ for TB Meningitis BPaLMZ Regimen - Tuberculous Meningitis, HIV | Phase 2 | Recruiting | David Boulware | 312 | 2026-07-28 | 2026-10-16 |
| Tuberculosis Clinical Registry in Europe data collection - Tuberculosis | Not yet recruiting | Research Center Borstel | 1000 | 2026-07-01 | 2026-07-01 | |
| Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis HRZE, HRZE plus Alpe375, HRZE plus AlpE500 - Tuberculosis Meningitis | Phase 2 | Not yet recruiting | BioVersys AG | 64 | 2026-03-30 | 2026-03-03 |
| Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA in Hong Kong Tuberculosis, Pleural, Pleural Biopsy | Recruiting | Chinese University of Hong Kong | 350 | 2026-01-01 | 2026-09-03 | |
| Study About Drug Resistance of Mycobacterium Tuberculosis Pulmonary and Extra- Pulmonary Tuberculosis (TB) | Not yet recruiting | Sohag University | 250 | 2025-10-01 | 2025-09-11 | |
| Adjunctive Doxycycline for Central Nervous System Tuberculosis Doxycycline, Placebo, Anti Tuberculosis Drug - Tuberculosis, Meningeal, Tuberculosis; Meningitis (Etiology) | Phase 2 | Recruiting | National University Hospital, Singapore | 200 | 2025-08-21 | 2026-06-01 |
| Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment Mycobacterium Tuberculosis, Tuberculosis, Pulmonary | Recruiting | University of Oxford | 140 | 2025-07-21 | 2026-04-13 | |
| Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA Mycobacterium tuberculosis (MTB) cell-free DNA (cfDNA) - Tuberculosis, Pleural | Recruiting | Chinese University of Hong Kong | 400 | 2025-04-01 | 2026-03-31 | |
| Shortened Regimen for Drug-susceptible TB in Children Isoniazid, Rifampin, Pyrazinamide - Tuberculosis, Tuberculosis, Pulmonary | Phase 3 | Recruiting | Johns Hopkins University | 860 | 2025-01-15 | 2026-07-24 |
| TBP Survey Among Respiratory Physicians Survey - Pleural Effusion, Tuberculosis, Pleural | Completed | Chinese University of Hong Kong | 418 | 2024-07-01 | 2026-03-30 | |
| Intensified Short Course Regimen for TBM in Adults High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg - Tuberculous Meningitis | Phase 3 | Not yet recruiting | Indian Council of Medical Research | 372 | 2024-03-01 | 2023-12-21 |
| Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis Contezolid, Linezolid (LZD) - Tuberculosis, Meningitis | Phase 1 / Phase 2 | Enrolling by invitation | Beijing Chest Hospital | 24 | 2024-02-01 | 2025-02-06 |
| Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis Rifampicin (RIF), Isoniazid (INH), Linezolid (LZD) - Tuberculous Meningitis | Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 330 | 2023-12-07 | 2026-06-02 |
| Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease NanoDetect-TB - Tuberculosis, Pulmonary, Tuberculosis, Extrapulmonary | Unknown | NanoPin Technologies, Inc. | 460 | 2023-08-01 | 2023-08-08 | |
| Applying Shear Wave Elastography for Adjunct Steroid on Tuberculous Lymphadenitis Prednisolone, standard anti-tuberculosis agents - Tuberculous Lymphadenitis | Not applicable | Unknown | National Taiwan University Hospital | 50 | 2023-05-01 | 2023-05-19 |
| Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis Adalimumab Injection - Tuberculous Meningitis, HIV I Infection | Phase 2 | Recruiting | ANRS, Emerging Infectious Diseases | 130 | 2023-04-11 | 2025-12-15 |
| A Prospective Observational Study on the Role of Transthoracic Ultrasound in Differentiating Tuberculous From Malignant Pleural Effusion Pleural Effusion, Tuberculosis, Pleural | Unknown | Sarawak General Hospital | 100 | 2023-04-01 | 2023-07-07 | |
| A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis biomarker analysis - Extrapulmonary Tuberculosis | Recruiting | University of Cologne | 150 | 2023-03-06 | 2025-03-13 | |
| Gene Expression Profiles in Spinal Tuberculosis. Tuberculosis, Spinal, Tuberculosis, Osteoarticular | Recruiting | University of Cape Town | 100 | 2022-10-25 | 2024-08-23 |
Showing 20 of 80. Sign in to see all of them.
Tuberculosis (31) · Tuberculosis, Meningeal (30) · Tuberculosis, Pleural (11) · Tuberculosis, Lymph Node (7) · Tuberculosis, Pulmonary (7) · Pleural Effusion (6) · Tuberculosis, Spinal (5) · Meningitis (4) · Acquired Immunodeficiency Syndrome (3) · Disease (3) · Latent Tuberculosis (3) · Peritonitis, Tuberculous (3) · Tuberculosis, Central Nervous System (3) · Tuberculosis, Female Genital (3)
Actinomycetales Infections (80) · Bacterial Infections (80) · Bacterial Infections and Mycoses (80) · Gram-Positive Bacterial Infections (80) · Infections (78) · Mycobacterium Infections (78) · Tuberculosis (49) · Central Nervous System Bacterial Infections (32) · Central Nervous System Infections (32) · Central Nervous System Diseases (31) · Nervous System Diseases (31) · Neuroinflammatory Diseases (31) · Meningitis, Bacterial (29) · Tuberculosis, Central Nervous System (29)
Rifampin (10) · Isoniazid (7) · Linezolid (6) · Aspirin (4) · Pyrazinamide (4) · Dexamethasone (3) · Ethambutol (3) · Moxifloxacin (3) · Prednisolone (3) · Methylprednisolone (2) · rifapentine (2) · 1-(2-fluoroethyl)-2-nitroimidazole (1) · 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1) · Adalimumab (1) · Antitubercular Agents (1)
Chinese University of Hong Kong (5) · Universitas Padjadjaran (5) · University of Cape Town (5) · Beijing Chest Hospital (4) · Oxford University Clinical Research Unit, Vietnam (4) · All India Institute of Medical Sciences (3) · Assistance Publique - Hôpitaux de Paris (3) · Huashan Hospital (3) · ANRS, Emerging Infectious Diseases (2) · Johns Hopkins University (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · National Taiwan University Hospital (2) · Post Graduate Institute of Medical Education and Research, Chandigarh (2) · Research Center Borstel (2) · University of Oxford (2)
China (11) · Indonesia (9) · South Africa (9) · India (8) · Hong Kong (5) · Vietnam (5) · France (4) · Germany (4) · Uganda (4) · Zambia (4) · Brazil (3) · Malawi (3) · Taiwan (3) · Zimbabwe (3) · Malaysia (2)
David SC Hui, MD (2) · Guy Thwaites, MD (2) · Rovina Ruslami, M.D., PhD (2) · Ahmad R Ganiem, MD, PhD (1) · Ahmed Metwally (1) · Aliasgar Esmail, MD FCP (1) · Alice M Muller, MD (1) · Angela Loyse, MD (1) · Angharad G Davis, Dr (1) · Chi-Li Chung, MD (1) · Chin-Chung Shu, MD (1) · Chung Yan Grace Lui (1) · Clifton E Barry, Ph.D. (1)
PMID 33283229, PMID 18216051, PMID 21420161, PMID 22174748, PMID 23103177, PMID 25178809, PMID 25703312, PMID 25969531, PMID 28424085, PMID 29202851, PMID 29482717, PMID 30224533, PMID 31847626, PMID 33616229, PMID 33972248, PMID 34286103, PMID 35291004, PMID 35506251, PMID 35767219, PMID 36348453, PMID 36439164, PMID 36482216, PMID 36795510, PMID 37233720, PMID 37740554, PMID 37802567, PMID 37819954, PMID 38693583, PMID 38918806, PMID 41540106, PMID 41874256
R01HD074944 (1), R21TW011035 (1)